Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tetraspanin8 expression predicts an increased metastatic risk and is associated with cancer-related death in human cutaneous melanoma.
Berthier-Vergnes O, Barbollat-Boutrand L, Pommier RM, de la Fouchardière A, Combemale P, Grimont M, Lopez-Ramirez N, Caramel J, Dalle S, Perrot JL, Gaudy-Marqueste C, Macagno N, Mansard S, Bouquet F, Masse I. Berthier-Vergnes O, et al. Among authors: caramel j. Mol Cancer. 2021 Oct 2;20(1):127. doi: 10.1186/s12943-021-01429-0. Mol Cancer. 2021. PMID: 34600553 Free PMC article. No abstract available.
ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Richard G, Dalle S, Monet MA, Ligier M, Boespflug A, Pommier RM, de la Fouchardière A, Perier-Muzet M, Depaepe L, Barnault R, Tondeur G, Ansieau S, Thomas E, Bertolotto C, Ballotti R, Mourah S, Battistella M, Lebbé C, Thomas L, Puisieux A, Caramel J. Richard G, et al. Among authors: caramel j. EMBO Mol Med. 2016 Oct 4;8(10):1143-1161. doi: 10.15252/emmm.201505971. Print 2016 Oct. EMBO Mol Med. 2016. PMID: 27596438 Free PMC article.
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.
Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, Mourah S. Louveau B, et al. Among authors: caramel j. Oncotarget. 2019 Mar 1;10(18):1669-1687. doi: 10.18632/oncotarget.26707. eCollection 2019 Mar 1. Oncotarget. 2019. PMID: 30899440 Free PMC article.
ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M, Benboubker V, Grimont M, Berthet J, Tonon L, Lopez J, Le-Bouar M, Balme B, Tondeur G, de la Fouchardière A, Larue L, Puisieux A, Grinberg-Bleyer Y, Bendriss-Vermare N, Dubois B, Caux C, Dalle S, Caramel J. Plaschka M, et al. Among authors: caramel j. J Immunother Cancer. 2022 Mar;10(3):e003484. doi: 10.1136/jitc-2021-003484. J Immunother Cancer. 2022. PMID: 35288462 Free PMC article.
Pleiotropic Roles for ZEB1 in Cancer.
Caramel J, Ligier M, Puisieux A. Caramel J, et al. Cancer Res. 2018 Jan 1;78(1):30-35. doi: 10.1158/0008-5472.CAN-17-2476. Epub 2017 Dec 18. Cancer Res. 2018. PMID: 29254997 Review.
34 results